Elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed multiple myeloma: A randomized phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8014 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8014-8014 ◽

Author(s):

P. G. G. Richardson ◽

P. Moreau ◽

A. J. Jakubowiak ◽

T. Facon ◽

S. Jagannath ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Study of Bortezomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Multiple Myeloma.

Case Medical Research ◽

10.31525/ct1-nct04277845 ◽

2020 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962446.793468191 ◽

2012 ◽

Author(s):

Steven Le Gouill ◽

Cyrille Touzeau

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Induction Therapy ◽

Phase Ii Study ◽

Randomized Phase Ii

Download Full-text

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

Bone Marrow Transplantation ◽

10.1038/bmt.2015.236 ◽

2015 ◽

Vol 51 (3) ◽

pp. 372-376 ◽

Author(s):

R Silvennoinen ◽

P Anttila ◽

M Säily ◽

T Lundan ◽

J Heiskanen ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Stem Cell Mobilization ◽

Randomized Phase Ii ◽

Cell Mobilization

Download Full-text

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study

British Journal of Haematology ◽

10.1111/bjh.14637 ◽

2017 ◽

Vol 178 (1) ◽

pp. 61-71 ◽

Author(s):

Orhan Sezer ◽

Meral Beksac ◽

Roman Hajek ◽

Gülsan Sucak ◽

Seckin Cagirgan ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Bone Disease ◽

Phase Ii Study ◽

Single Agent ◽

Consolidation Therapy ◽

Post Transplant ◽

Randomized Phase Ii

Download Full-text

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial

Haematologica ◽

10.3324/haematol.2018.205476 ◽

2019 ◽

Vol 104 (11) ◽

pp. 2265-2273 ◽

Author(s):

Ruth Wester ◽

Bronno van der Holt ◽

Emelie Asselbergs ◽

Sonja Zweegman ◽

Marie Jose Kersten ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Newly Diagnosed

Download Full-text

Correlation of immune responses with survival in a randomized phase II study investigating multipeptide vaccination with IMA901 plus or minus low-dose cyclophosphamide in advanced renal cell carcinoma (RCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.2587 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2587-2587 ◽

Author(s):

H. Singh ◽

N. Hilf ◽

R. Mendrzyk ◽

D. Maurer ◽

T. Weinschenk ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Immune Responses ◽

Cell Carcinoma ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Advanced Renal Cell Carcinoma ◽

Randomized Phase Ii

Download Full-text

A randomized phase II study of stem cell mobilization with cyclophosphamide + G-CSF versus G-CSF alone after lenalidomide-based induction in multiple myeloma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.07.337 ◽

2015 ◽

Vol 15 ◽

pp. e138

Author(s):

R. Silvennoinen ◽

P. Anttila ◽

M. Säily ◽

T. Lundan ◽

J. Heiskanen ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Stem Cell Mobilization ◽

Randomized Phase Ii ◽

Cell Mobilization

Download Full-text

(F7) Randomized phase II study with GM-CSF and low-dose ARAC in patients with “high risk” myelodysplastic syndromes

Leukemia Research ◽

10.1016/0145-2126(91)90376-5 ◽

1991 ◽

Vol 15 ◽

pp. 14

Keyword(s):

High Risk ◽

Phase Ii ◽

Myelodysplastic Syndromes ◽

Low Dose ◽

Phase Ii Study ◽

Gm Csf ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13759956.15180056 ◽

2012 ◽

Author(s):

Luis Bahamondes ◽

Valeria Bahamondes

Keyword(s):

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Intrauterine Contraceptive

Download Full-text

Randomized phase II study of clofarabine versus clofarabine plus low-dose cytarabine (ara-C) for patients (pts) ≥ 60 years (yrs) with newly diagnosed acute myeloid leukemia (AML)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6627 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6627-6627 ◽

Author(s):

S. Faderl ◽

F. Ravandi-Kashani ◽

A. Ferrajoli ◽

Z. Estrov ◽

W. Wierda ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Low Dose ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Randomized Phase Ii ◽

Low Dose Cytarabine ◽

Download Full-text